Medicine man has right rememdy
10 April 2016
Amryt Pharma has a healthy future under boss Joe Wiley, as it heads for a €62m flotation that could help fund a drugs revolution...
Corporate Finance Adviser to
on its initial fundraising of $8m
Corporate Finance Adviser to Fastnet Oil & Gas plc
on the farm-out to SK Innovation of a 12.5% interest in the Foum Assaka licence, offshore Morocco
Corporate Finance Adviser to
on its £10m Equity Placing in November 2013
Corporate Finance Adviser to
on its £10m IPO on the AIM market of the London Stock Exchange
Trade Sale Advisor to Major Shareholder of
on its sale to RSA for €65m
Trade Sale Adviser to
on its sale to Affinion International for €20m+
Trade Sale Adviser to
on its sale to Exponent Private Equity for €170m
Trade Sale Adviser to
on its sale to NASDAQ quoted Verint Systems for $20m+
Trade Sale Adviser to EMAP Plc
on the Sale of its Irish Radio Assets for €200m
Latest News
- 05 September 2016: Raglan Capital backs Ireland’s first entrant in Vendee Globe non-stop around the world yacht race by Enda O’Coineen.
- 19 April 2016: Shareholders back Fastnet's Amryt move
- 10 April 2016: Medicine man has right rememdy
- 10 April 2016: Amryt offers stock booster to its leading Irish backers
- 10 April 2016: Sudocrem boss: new skin drug will net €1.5bn
- 05 April 2016: Fastnet chief explains switch to pharma
- 03 April 2016: Sudocrem man Stafford is on board for Amryt deal
- 02 April 2016: Shire founder eyes further success as Amryt chairman
- 01 April 2016: Fastnet Equity in €37m debut deal
- 31 March 2016: Submission of Admission Document Coverage
